EX-21.1 5 ex21-1.htm

 

EXHIBIT 21.1

 

Subsidiaries of Sanara MedTech Inc.

 

The following is a list of subsidiaries of Sanara MedTech Inc., a Texas corporation (the “Company”), as of December 31, 2024, the states in which they are organized and the Company’s percentage ownership of the issued and outstanding stock or other equity interests for each entity. The names of particular subsidiaries may be omitted if the unnamed subsidiaries, considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary as of the end of the year covered by the annual report on Form 10-K of which this Exhibit 21.1 forms a part. (See the definition of “significant subsidiary” in Rule 1-02(w) (17 CFR 210.1-02(w)) of Regulation S-X.)

 

Name of Subsidiary  State of Incorporation  Direct or
Indirect Ownership Percentage
 
Cellerate, LLC  Texas   100%
Wound Care Innovations, LLCTT  Nevada   100%
Sanara CMP, LLC  Texas   100%(1)
Rochal Technologies, LLC  Texas   100%
Tissue Health Plus, LLC  Delaware   100%(2)
Precision Healing, LLC  Delaware   100%(3)
Pixalere Healthcare USA, LLC  Delaware   73%(4)
Scendia Biologics, LLC  Delaware   100%
Sanara MedTech Applied Technologies, LLC  Texas   100%
Sanara Collagen Peptides, LLC  Delaware   90%

 

(1) In 2024, Sanara Biologics, LLC was renamed to Sanara CMP, LLC.

 

(2) In 2024, United Wound and Skin Solutions, LLC was renamed to Tissue Health Plus, LLC.

 

(3) Ownership of Precision Healing, LLC is held indirectly through Tissue Health Plus, LLC, a wholly owned subsidiary of the Company.

 

(4) Ownership of Pixalere Healthcare USA, LLC is held indirectly through Tissue Health Plus, LLC, a wholly owned subsidiary of the Company.